|
⚲
|
| Redmile Group LLC
✚
|
|
|---|---|
| CRD # | 143606 |
| SEC # | 801-67747 |
| CIK # | 0001425738 |
| AUM | $6.5 BB (2024-07-03) |
| Employees | 35 (57% Investors, 0% Brokers) |
| Phone | 415-489-9980 |
| Address | One Letterman Drive San Francisco, CA 94129 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($BB) |
|---|
| CIK | Period |
|---|---|
| 0001425738 | |
| / | |
| Sector | Form 13F Holdings | Cap ($BB) | Value ($BB) |
|---|---|---|---|
| Krystal Biotech Inc | 1.7 | 0.2 | |
| Amicus Therapeutics Inc | 3.0 | 0.1 | |
| Nurix Therapeutics Inc | 0.5 | 0.1 | |
| Stoke Therapeutics Inc | 0.5 | 0.1 | |
| Immunome Inc | 0.0 | 0.1 | |
| RegenxBio Inc | 1.1 | 0.1 | |
| Livanova PLC | 3.4 | 0.1 | |
| Replimune Group Inc | 0.8 | 0.1 | |
| ADC Therapeutics Sa | 0.6 | 0.0 | |
| Kymera Therapeutics Inc | 1.0 | 0.0 | |
| Scholar Rock Holding Corp | 0.3 | 0.0 | |
| Zymeworks Inc | 0.3 | 0.0 | |
| Fate Therapeutics Inc | 2.4 | 0.0 | |
| UNUM Therapeutics Inc | 0.6 | 0.0 | |
| Beam Therapeutics Inc | 2.8 | 0.0 | |
| Silence Therapeutics PLC | 0.3 | 0.0 | |
| Akero Therapeutics Inc | 0.4 | 0.0 | |
| Biohaven Ltd | 10.3 | 0.0 | |
| Aquinox Pharmaceuticals Inc | 0.0 | ||
| Pliant Therapeutics Inc | 0.3 | 0.0 | |
| Catalent Inc | 19.2 | 0.0 | |
| Annexon Inc | 0.2 | 0.0 | |
| Boston Scientific Corp | 53.6 | 0.0 | |
| IDEAYA Biosciences Inc | 0.5 | 0.0 | |
| Celldex Therapeutics Inc | 1.3 | 0.0 | |
| Absci Corp | 0.3 | 0.0 | |
| Keros Therapeutics Inc | 0.6 | 0.0 | |
| ALX Oncology Holdings Inc | 0.3 | 0.0 | |
| 4D Molecular Therapeutics Inc | 0.2 | 0.0 | |
| Shattuck Labs Inc | 0.2 | 0.0 | Prev | Page 1 | Next |
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| HF | Redmile Strategic Long Only Trading Sub Ltd | [2022-08-15] | 490.7 | 285.8 |
| HF | Redmile Strategic Trading Sub Ltd | [2022-08-15] | 490.7 | 211.9 |
| VC | Redmile Growth Investments I LP | [2022-02-09] | 122.0 | 156.8 |
| PE | RM Special Holdings 8 LLC | 2022-02-09 | 1.2 | |
| HF | Redco II Master Fund LP | [2021-03-31] | 31.4 | 1,518.8 |
| PE | Redmile Biopharma Investments III LP | [2021-02-26] | 500.2 | 1,152.2 |
| PE | RM Special Holdings 4 LLC | 2021-02-26 | 44.9 | |
| HF | Redco I LP | [2020-08-27] | 187.5 | 109.3 |
| VC | Redmile Biopharma Investments II LP | [2019-03-29] | 675.4 | 828.5 |
| HF | Redmile Capital Offshore II Master Fund Ltd | 2019-03-29 | 961.5 | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($BB) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 27 | 6.5 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 27 | 6.5 |
| By Discretionary | ||
| Discretionary | 27 | 6.5 |
| Non-Discretionary | 0 | 0.0 |
| Total | 27 | 6.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 4.2 | |
| United States Persons | 2.2 | |
| Total | 27 | 6.5 |
| Form D Directors | # Filings | # Firms | 2011 - 2024 | |
|---|---|---|---|---|
| Ronan Guilfoyle | 345 | |||
| Roger Hanson | 255 | |||
| Vijayabalan Murugesu | 126 | |||
| Philip Hughes | 84 | |||
| Mike Lee | 20 | |||
| Gerard van Hamel Platerink | 19 | |||
| Jeremy Green | 16 | |||
| Redmile Group LLC | 10 | |||
| Amrit Nagpal | 10 | |||
| Rob Faulkner | 3 | |||
| View All | ||||
| EDGAR Form | CIK | 2011 - 2024 |
|---|---|---|
| 13F-HR | [0001425738] | |
| 3 | [0001425738] | |
| 4 | [0001425738] | |
| SC 13D | [0001425738] | |
| SC 13G | [0001425738] |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
Trive Capital Management LLC
✚
|
TX | 6.7 |
|
Blue Torch Capital LP
✚
|
NY | 6.7 |
|
Sun Capital Advisors LP
✚
|
FL | 6.6 |
|
NXT Capital Investment Advisers LLC
✚
|
IL | 6.6 |
|
Torchlight Investors LLC
✚
|
NY | 6.5 |
|
Anchorage Capital Group LLC
✚
|
NY | 6.3 |
|
Axonic Capital LLC
✚
|
NY | 6.3 |
|
First Reserve Management LP
✚
|
CT | 6.1 |
|
Denham Capital Management LP
✚
|
MA | 6.1 |
|
OGAM LP
✚
|
TX | 6.1 |